PET assessment of myocardial perfusion reserve inversely correlates with intravascular ultrasound findings in angiographically normal cardiac transplant recipients

YW Wu, YH Chen, SS Wang, HY Jui… - Journal of Nuclear …, 2010 - Soc Nuclear Med
Cardiac allograft vasculopathy (CAV) is the major determinant of long-term survival after
heart transplantation. We aimed to evaluate the efficacy of PET as a noninvasive way to …

Comparative prognostic and diagnostic value of myocardial blood flow and myocardial flow reserve after cardiac transplantation

RJH Miller, O Manabe, B Tamarappoo… - Journal of Nuclear …, 2020 - Soc Nuclear Med
Cardiac allograft vasculopathy (CAV) is a major cause of graft failure after cardiac
transplantation. CAV is characterized by diffuse involvement of epicardial coronary arteries …

Prognostic utility of longitudinal quantification of PET myocardial blood flow early post heart transplantation

C Wiefels, A Almufleh, J Yao, RA DeKemp… - Journal of Nuclear …, 2022 - Elsevier
Background Myocardial blood flow (MBF) quantification by Rubidium-82 positron emission
tomography (PET) has shown promise for cardiac allograft vasculopathy (CAV) surveillance …

Validation of multiparametric rubidium-82 PET myocardial blood flow quantification for cardiac allograft vasculopathy surveillance

S Chih, AY Chong, J Bernick, GA Wells… - Journal of Nuclear …, 2021 - Elsevier
Background We previously demonstrated high diagnostic accuracy of Rubidium-82 positron
emission tomography (PET) myocardial blood flow (MBF) quantification for CAV. The …

Noninvasive physiologic assessment of cardiac allograft vasculopathy is prognostic for post-transplant events

KJ Clerkin, VK Topkara, MA Farr, R Jain… - Journal of the American …, 2022 - jacc.org
Background Cardiac allograft vasculopathy (CAV) causes impaired blood flow in both
epicardial coronary arteries and the microvasculature. A leading cause of post-transplant …

Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy

PE Bravo, BA Bergmark, T Vita, VR Taqueti… - European heart …, 2018 - academic.oup.com
Aims Cardiac allograft vasculopathy (CAV) is a leading cause of death in orthotopic heart
transplant (OHT) survivors. Effective non-invasive screening methods are needed. Our aim …

PET myocardial blood flow for post-transplant surveillance and cardiac allograft vasculopathy in heart transplant recipients

A Feher, EJ Miller - Current Cardiology Reports, 2022 - Springer
Abstract Purpose of Review Cardiac allograft vasculopathy (CAV) is a late-occurring
complication of heart transplantation significantly limiting overall graft survival. In the last few …

PET assessment of epicardial intimal disease and microvascular dysfunction in cardiac allograft vasculopathy

S Chih, AY Chong, F Erthal, RA deKemp… - Journal of the American …, 2018 - jacc.org
Background: Cardiac allograft vasculopathy (CAV) is a leading cause of graft failure and
death after heart transplantation. Absolute myocardial blood flow (MBF) quantification using …

Negative predictive value and prognostic associations of Rb-82 PET/CT with Myocardial Blood flow in CAV

BQ Abadie, N Chan, Z Sharalaya, P Bhat, S Harb… - Heart Failure, 2023 - jacc.org
Background Invasive coronary angiography (ICA) is the traditional screening modality for
cardiac allograft vasculopathy (CAV). Positron emission tomography/computed tomography …

Single photon emission computed tomography myocardial perfusion imaging to detect cardiac allograft vasculopathy

D Thompson, MJ Koster, RH Wagner… - European Heart …, 2012 - academic.oup.com
Aims Cardiac allograft vasculopathy (CAV) is a major cause of morbidity and mortality in
cardiac transplant recipients. This study evaluates the usefulness of single photon emission …